Amevive is a prescription medication used to treat moderate to severe plaque psoriasis in adults. This medication is classified as a biologic therapy, specifically a recombinant human immunoglobulin G1 (IgG1) monoclonsubtype that targets specific immune cells involved in the inflammatory response seen in psoriasis.

Amevive works by binding to the CD2 receptor on T cells, which helps to reduce the excessive immune response that leads to the development of psoriatic plaques. By targeting these specific immune cells, Amevive helps to decrease the inflammation and scaling associated with psoriasis, leading to clearer skin for many patients.

It is important to note that Amevive is not a cure for psoriasis, but rather a treatment option that can help manage symptoms and improve quality of life for those living with this chronic skin condition. It is typically administered as an injection under the skin, with dosing frequency determined by your healthcare provider based on your individual needs and response to treatment.

As with any medication, Amevive may cause side effects in some individuals. Common side effects may include headache, nausea, and injection site reactions. It is important to discuss any concerns or potential side effects with your healthcare provider before starting treatment with Amevive.

Overall, Amevive can be an effective treatment option for individuals with moderate to severe plaque psoriasis. If you believe Amevive may be a suitable option for you, I encourage you to speak with your healthcare provider to discuss the potential benefits and risks of this medication in relation to your specific condition.